Abnormal Expression of MDM2 in Prostate Carcinoma
- 1 May 2001
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (5) , 428-436
- https://doi.org/10.1038/modpathol.3880330
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Fast and sensitive silver staining of DNA in polyacrylamide gelsPublished by Elsevier ,2004
- Overexpression of MDM2 in Acute Childhood Lymphoblastic LeukemiaPediatric Hematology and Oncology, 1998
- Strong Correlation of Basement Membrane Degradation With P53 Inactivation and/or MDM2 Overexpression in Superficial Urothelial CarcinomasJournal of Urology, 1997
- A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS ANDp53 GENE PRODUCT IN BRONCHOGENIC CARCINOMAThe Journal of Pathology, 1996
- Abnormal expression of MDM-2 in breast carcinomasBreast Cancer Research and Treatment, 1996
- MDM2 Amplification, P53 Mutation, and Accumulation of the P53 Gene Product in Malignant Fibrous HistiocytomaDiagnostic Molecular Pathology, 1996
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 AccumulationJNCI Journal of the National Cancer Institute, 1992
- The TNM classification of prostate cancerThe Prostate, 1992